COPG1

mass-spec protein & survival
Survivalmass-specKaplan–Meier · TCGA cohorts

Across TCGA pan-cancer cohorts, COPG1 mass-spec protein is linked to patient survival in 7 of 34 cancer types, making it a survival-associated COPG1 data layer compared with 22 for mass-spec protein and 2 for mutation status.

The strongest signal is observed in lung squamous cell carcinoma (LSCC), where higher COPG1 mass-spec protein is associated with worse overall survival. In most high-consensus cancer types, elevated COPG1 expression acts as an unfavorable survival marker, although some lineages such as HNSC and PDAC show a favorable association.

LSCC, CCRCC, and HNSC are the cancer types where COPG1 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.
LineageMeasureSplitStageAUC1
high
AUC2
low
pSampling consensus
LSCCOSQuartileII,III,IV0.4691.000<.00139view →
CCRCCDFSQuartileIII,IV0.3620.805.00726view →
HNSCDFSMedianIII,IV0.8960.690.00124view →
GBMDFSQuartileAll0.6560.874.00111view →
PDACDFSQuartileII,III,IV0.9000.667.0186view →
UCECDFSTertileAll0.9740.842.0146view →
LUADOSMedianAll0.9030.676.0251view →
Pink = unfavorable, green = favorable. Showing the 7 strongest of 7 lineages.

COPG1–LSCC (OS)

Kaplan–Meier survival curve for COPG1 mass-spec protein-high vs -low samples in LSCC.

Open the LSCC breakdown →

Exploration